Dr. Diamond is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-689-5555Fax+1 305-243-0424
Summary
- plasma cell disorders, multiple myeloma, computational genomics, MRD
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2015 - 2018
- Boston University School of MedicineClass of 2015
Certifications & Licensure
- FL State Medical License 2021 - 2025
- NY State Medical License 2017 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission Start of enrollment: 2020 Jan 03
Publications & Presentations
PubMed
- Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma.Holly Lee, Michael Durante, Sheri Skerget, Deeksha Vishwamitra, Sacha Benaoudia
Blood. 2024-12-19 - Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignancies.Benjamin Diamond, Dhanvantri Chahar, Michael D Jain, Alexandra M Poos, Michael Durante
Biorxiv. 2024-11-18 - From MGUS to multiple myeloma: Unraveling the unknown of precursor states.Gil Hevroni, Mounika Vattigunta, Dickran Kazandjian, David Coffey, Benjamin Diamond
Blood Reviews. 2024-11-01
Press Mentions
- Mission Bio and University of Miami Collaborate on Multiple Myeloma ResearchDecember 2nd, 2024
- Mission Bio Announces Partnership to Advance Multiple Myeloma InsightsDecember 2nd, 2024
- Mission Bio Partners with Top Researchers from University of Miami to Accelerate Early Relapse Detection & Treatment Selection of Multiple Myeloma PatientsDecember 2nd, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: